Generics and Biosimilars: Mapping the Biosimilars Regulatory Approval Pathway Against the Hatch-Waxman Act and Projecting Futures Effects on the Biologics Market and Patent Protection

Spring 2014Articles University of Pittsburgh Law Review, Volume 75

Click here to view the full article.